Boston, MA 04/02/2014 (wallstreetpr) – Highpower International Inc (NASDAQ:HPJ) shares exploded during trading Tuesday, touching a new 52-week high and shifting above average volume. The company reveals strength in its revenue generation which has outpaced the growth of the industry average having gone up 24.7 percent year-over-year as noted in the most recent quarter, against 5.7 percent industry average over the same duration. Interestingly, the revenue growth has found its way into the bottom line, thus improving earnings per share. Earnings per share have gone up 125 percent in the past year, a period during which the stock price also moved up 319.45 percent. Thus the stock price growth outperformed the S&P 500 Index over the same duration. But even so Highpower International Inc (NASDAQ:HPJ) reveals worrisome debt burden and unclear earnings pattern in the past two years. It is difficult to get a better picture of how earnings might be in the coming year. Thus additional investment in the stock may not be recommended, but those already invested in the stock can hold onto their position.
Sungy Mobile Ltd (NASDAQ:GOMO) which was up more than 18 percent on the back of double the normal volume, continued to find support from its strong earnings report and the prospects which investors can see in the company. The company reported 20 cents EPS in its fourth quarter results issued last week, beating the consensus EPS at 9 cents. The company provides mobile Internet products which are growing very popular around the world. The data recently released by ComScore revealed that more Americans accessed the Internet on their mobile devices than they did on their PC and this trend is catching up in many more markets around the world as smartphones increase their penetration. With the launch of Go Launcher EX Internet platform for mobile devices and its $5.3 million acquisition of GetJar last month, Sungy Mobile Ltd (NASDAQ:GOMO) looks well-placed to benefit from the advantages which its market provides. The company obtains 60 percent of its revenue from subscription, advertisement and app sales in the U.S. market.
IsoRay, Inc. (NYSEMKT:ISR) was in an exciting atmosphere Tuesday after the company announced upcoming participation at a major medical meet. The company announced that it will use the presentation at the medical conference to offer insight into Cesium-131, which recently showed encouraging results in dealing with cancer conditions. Company executives will feature the drug in five separate presentations between April 3 and 5.
Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.